Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGF1 | P05230 | 1/20 | 0.35 |
| ▸ | IGF2R | P11717 | 2/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.32 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.32 |
| ▸ | LGALS4 | P56470 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MAG | P20916 | 2/20 | 0.32 |
| ▸ | GJA1 | P17302 | 1/20 | 0.31 |
| ▸ | GJB2 | P29033 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16909331 | 0.93 | PTPN1 (0.36) | FGF1PTPN1LGALS8LGALS3LGALS4 | |
| SCHEMBL17867165 | 0.89 | IGF2R (0.41) | IGF2RPTPN1LGALS8LGALS3LGALS4 | |
| SCHEMBL21206254 | 0.89 | IGF2R (0.41) | IGF2RPTPN1LGALS8LGALS3LGALS4 | |
| SCHEMBL16431846 | 0.89 | IGF2R (0.41) | IGF2RPTPN1LGALS8LGALS3LGALS4 | |
| SCHEMBL7627973 | 0.87 | CD209 (0.37) | FGF1IGF2RPTPN1LGALS8LGALS3 | |
| SCHEMBL15373700 | 0.84 | LGALS8 (0.44) | IGF2RLGALS8LGALS3LGALS4MEN1 | |
| SCHEMBL12362685 | 0.84 | LGALS8 (0.44) | IGF2RLGALS8LGALS3LGALS4MEN1 | |
| SCHEMBL14936334 | 0.84 | LGALS8 (0.44) | IGF2RLGALS8LGALS3LGALS4MEN1 | |
| SCHEMBL14936496 | 0.84 | LGALS8 (0.44) | IGF2RLGALS8LGALS3LGALS4MEN1 | |
| SCHEMBL17223127 | 0.84 | LGALS8 (0.44) | IGF2RLGALS8LGALS3LGALS4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10751362-B2 | Compositions and methods for managing digestive disorders and a healthy microbiome | METAGENICS, INC. (US) | 2020-08-25 | — | — | US | disclosed |
| US-20180015032-A1 | COMPOSITIONS AND METHODS FOR MANAGING DIGESTIVE DISORDERS AND A HEALTHY MICROBIOME | WHITEHORSE CAPITAL ORIGINATION, LLC, AS AGENT | 2018-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180015032-A1 | COMPOSITIONS AND METHODS FOR MANAGING DIGESTIVE DISORDERS AND A HEALTHY MICROBIOME | FUCA2, SI, FUCA1 | FGF1 303/4885IGF2R 79/4885PTPN1 3834/4885 |
| US-10751362-B2 | Compositions and methods for managing digestive disorders and a healthy microbiome | FUCA2, SI, FUCA1 | FGF1 303/4885IGF2R 79/4885PTPN1 3834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.